Transcatheter Aortic Valve Replacement (TAVR) is a novel heart surgery approved only 4 years ago. Since the approval, the records of this type of surgery has been maintained in the USA. The results of the assessment of the data of this registry suggest that it has helped improve outcomes of cardiac surgery. Transcatheter Aortic Valve Replacement (TAVR) is a minimally invasive cardiac valve replacement surgery. This surgery has been approved only 4 years ago by Food and Drug Administration (FDA), USA for aortic stenosis.
Aortic stenosis is a life-threatening condition in which aortic valve openings narrow, as a result blood flow from the heart to rest of the body is restricted. Due to the aortic stenosis, a heart is pushed to work harder and hence the valves become weak due to increased pressure. Currently, open-heart surgeries are the most common procedures for valve replacement. TAVR…
